U.S. Global Health Policy One Year In to the Trump Administration
A new Kaiser Family Foundation issue brief assessing global health policy one year after President Trump took office finds half of Americans (54%) say they want the
View the Latest: PEPFAR
Filter
-
-
A Check Up on U.S. Global Health Policy, After One Year of the Trump Administration
Issue BriefIn this brief, we take stock of the U.S. global health response on the occasion of one year of the Trump Presidency and look ahead to the global health policy issues that are likely to be front and center in the coming months and years. We include a discussion of new KFF polling data (from January 2018) to provide an updated assessment of U.S. public support for global health programs.
-
Quantifying PEPFAR’s Role for Women and Girls: Analysis of Monitoring, Evaluation, and Reporting Indicator Data, 2016-2019
FeatureWomen and girls represent more than half of all people living with HIV worldwide, and HIV is the leading cause of death among women aged 15-49. This analysis sought to quantify PEPFAR’s role for women and girls in key program areas, analyzing data over time as well as by country, to better understand the extent of its reach.
-
COVID-19 & PEPFAR: Implications for the Future
Issue BriefThe potential for the COVID-19 pandemic to significantly affect the health and development of low- and middle-income countries (LMICs), particularly those in sub-Saharan Africa, has serious implications for PEPFAR, the President’s Emergency Plan for AIDS Relief (PEPFAR). This issue brief examines the steps PEPFAR has taken to respond to the outbreak and the issues at stake.
-
The U.S. Global Health Budget: Analysis of Appropriations for Fiscal Year 2016
Issue BriefAfter Congress provided an unprecedented level of emergency funding for Ebola in FY15 in response to the West African outbreak, beyond regular appropriations for global health programs, FY16 returned to business as usual. There was no additional emergency funding and global health amounts remained essentially flat funding compared to prior years. The FY16 Omnibus Appropriations bill, which was signed into law by the President on December 18, 2015, included an estimated $10.2 billion in funding for global health programs continuing a trend of essentially flat funding since FY10.
-
U.S. Global Health Legislation Tracker
Fact SheetThis tracker provides a listing of global health-related legislation introduced in the current Congress.
-
New KFF Analysis Finds 40 Out of 46 PEPFAR Countries Have Met At Least One HIV Target, Though No Countries Have Met All Progress Measures
News ReleaseA new KFF analysis finds that across 46 PEPFAR countries and among six different indicators of progress, the majority (40) has met at least one target, 17 countries have met at least half of the targets, and one country has met five targets.
-
Assessing Global HIV Targets in PEPFAR Countries: A Dashboard
Issue BriefA new KFF analysis finds that across 46 PEPFAR countries and among six different indicators of progress, the majority (40) has met at least one target. The analysis is part of a dashboard that provides a detailed look at progress being made to address the HIV/AIDS epidemic in countries where PEPFAR operates.
-
What Will Be the Contours of the Biden Administration’s Global Health Agenda?
Issue BriefThis issue brief provides an overview of the Biden administration’s COVID-19 and global health actions to date, as well as likely ones on the horizon, and identifies key policy issues and outstanding questions ahead.
-
Funding for Key HIV Commodities in PEPFAR Countries
Issue BriefIn many low- and middle-income countries, PEPFAR and the Global Fund are significant funders of commodities to diagnose, treat, and prevent HIV, along with country governments. But, information on their relative contributions, which is important for assessing the HIV response, is not readily available. We analyzed data from PEPFAR documents on funding for key HIV commodities in 34 PEPFAR countries to better understand the funding landscape.